Description

MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT is a agent-linker conjugate for antibody-drug conjugate (ADC). MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT has the potential for cancer and autoimmune disease research.–Applications-COVID-19-immunoregulation-Formula-C62H87N9O21-Citation–References-[1]Scott C. Jeffrey, et al. Camptothecin peptide conjugates. WO2021067861A1.-CASNumber-2639190-44-4-MolecularWeight-1294.40-Compound Purity–SMILES-O=C(C=CC1=O)N1CCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCC(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@H](C)C(NCC2=C3C(C(N4C3)=CC([C@](O)(C(OC5)=O)CC)=C5C4=O)=NC6=CC(OCO7)=C7C=C62)=O)=O)=O)=O)=O-Research_Area-Cancer; Inflammation/Immunology-Solubility-10 mM in DMSO-Target-Drug-Linker Conjugates for ADC-Isoform-Camptothecins-Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related